• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性糖性白内障中晶状体蛋白的非酶糖基化、巯基氧化及聚集

Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts.

作者信息

Monnier V M, Stevens V J, Cerami A

出版信息

J Exp Med. 1979 Nov 1;150(5):1098-107. doi: 10.1084/jem.150.5.1098.

DOI:10.1084/jem.150.5.1098
PMID:501285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2185697/
Abstract

The formation of sugar-cataracts has been hypothesized to involve the nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins. Cataractous lenses of diabetic and galactosemic rats were analyzed for glycosylated lysine residues in crystallins. A five- and a ten-fold increase in glycosylated lysine residues was measured in galactose and diabetic cataracts, respectively. The modification was predominant in the insoluble fraction of the lens homogenate. The proteins were further examined for the presence of disulfide bonds and high molecular weight aggregates. After careful disruption of the lens in a nitrogen environment, a cloudy solution was obtained from cataractous lenses whereas a clear solution was obtained from normal lenses. The absorbance at 550 nm of the solution of both the galactosemic and the diabetic cataracts could be decreased by approximately 50% with the addition of dithioerythritol (50 mM). The presence of high molecular weight aggregates was ascertained by sucrose gradient centrifugation and gel filtration chromatography. The proteins were heterogenous in size and showed a mol wt range of 36 to greater than 176 million daltons. Treatment with dithioerythritol induced a marked decrease in the amount of high molecular weight proteins. These data suggest that sugar cataracts of experimental animals have, in common with human cataracts, the presence of high molecular weight aggregates which are in part linked by disulfide bonds.

摘要

糖性白内障的形成被认为涉及晶状体蛋白的非酶糖基化、巯基氧化和聚集。分析了糖尿病和半乳糖血症大鼠的白内障晶状体中晶状体蛋白的糖基化赖氨酸残基。在半乳糖性和糖尿病性白内障中,分别检测到糖基化赖氨酸残基增加了5倍和10倍。这种修饰在晶状体匀浆的不溶性部分中占主导地位。进一步检测了蛋白质中二硫键和高分子量聚集体的存在。在氮气环境中小心地破坏晶状体后,白内障晶状体得到浑浊溶液,而正常晶状体得到清澈溶液。加入二硫苏糖醇(50 mM)后,半乳糖血症和糖尿病性白内障溶液在550 nm处的吸光度可降低约50%。通过蔗糖梯度离心和凝胶过滤色谱法确定了高分子量聚集体的存在。这些蛋白质大小不均一,分子量范围为36至大于1.76亿道尔顿。用二硫苏糖醇处理导致高分子量蛋白质的量显著减少。这些数据表明,实验动物的糖性白内障与人类白内障一样,存在部分由二硫键连接的高分子量聚集体。

相似文献

1
Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts.实验性糖性白内障中晶状体蛋白的非酶糖基化、巯基氧化及聚集
J Exp Med. 1979 Nov 1;150(5):1098-107. doi: 10.1084/jem.150.5.1098.
2
Diabetic cataract formation: potential role of glycosylation of lens crystallins.糖尿病性白内障的形成:晶状体蛋白糖基化的潜在作用。
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2918-22. doi: 10.1073/pnas.75.6.2918.
3
Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: in vitro and in vivo studies.泼尼松龙对晶状体蛋白的非酶修饰诱导巯基氧化和聚集体形成:体外和体内研究
Exp Eye Res. 1985 Sep;41(3):353-63. doi: 10.1016/s0014-4835(85)80026-9.
4
Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats.链脲佐菌素诱导的糖尿病大鼠晶状体蛋白氧化与白内障形成之间的时间关系。
Physiol Res. 2005;54(1):49-56. doi: 10.33549/physiolres.930613.
5
Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats.链脲佐菌素诱导的糖尿病大鼠晶状体结晶蛋白糖基化的渐进性变化及高分子量聚集体形成导致白内障发展
Exp Eye Res. 1987 Feb;44(2):269-82. doi: 10.1016/s0014-4835(87)80011-8.
6
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts.糖基化在糖尿病性和非糖尿病性老年性白内障晶状体蛋白修饰中的作用。
Diabetes. 1991 Aug;40(8):1010-5. doi: 10.2337/diab.40.8.1010.
7
Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products.过渡金属催化人白内障提取物中抗坏血酸的氧化:晚期糖基化终产物的可能作用。
Invest Ophthalmol Vis Sci. 2000 May;41(6):1473-81.
8
Nonenzymatic glycosylation (glycation) of lens crystallins in diabetes and aging.糖尿病和衰老过程中晶状体晶状体蛋白的非酶糖基化(糖基化)
Prog Clin Biol Res. 1989;304:123-39.
9
The decrease of free epsilon-amino groups in senile and diabetic cataracts.老年性和糖尿病性白内障中游离ε-氨基的减少。
Ophthalmic Res. 1990;22(3):160-5. doi: 10.1159/000267017.
10
Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.醛糖还原酶与非酶糖基化在糖尿病大鼠糖性白内障形成中的相对重要性
J Ocul Pharmacol Ther. 2000 Apr;16(2):149-60. doi: 10.1089/jop.2000.16.149.

引用本文的文献

1
The Effects of Lutein-Containing Supplement Intake on Glycation Inhibition Among Diabetic Patients with Cataracts.含叶黄素补充剂摄入对糖尿病性白内障患者糖基化抑制的影响。
Int J Mol Sci. 2025 Jun 13;26(12):5706. doi: 10.3390/ijms26125706.
2
On the Anticataractogenic Effects of L-Carnosine: Is It Best Described as an Antioxidant, Metal-Chelating Agent or Glycation Inhibitor?关于L-肌肽的抗白内障作用:将其描述为抗氧化剂、金属螯合剂还是糖基化抑制剂最为恰当?
Oxid Med Cell Longev. 2016;2016:3240261. doi: 10.1155/2016/3240261. Epub 2016 Oct 16.
3
Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract.探讨巨峰醇与丁香酸联合预防糖尿病性白内障时醛糖还原酶的协同作用机制及相互作用位点的鉴定。
BMC Complement Altern Med. 2016 Aug 12;16(1):286. doi: 10.1186/s12906-016-1251-5.
4
Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.脂质体镁原卟啉在半乳糖喂养大鼠中抗白内障作用的机制
Mol Vis. 2016 Jul 10;22:734-47. eCollection 2016.
5
Effects of topically applied tocotrienol on cataractogenesis and lens redox status in galactosemic rats.局部应用生育三烯酚对半乳糖血症大鼠白内障形成及晶状体氧化还原状态的影响。
Mol Vis. 2014 Jun 12;20:822-35. eCollection 2014.
6
Increased non-enzymatic glycation of plasma proteins and hemoglobin in non-diabetic patients with acute myocardial infarction (MI).非糖尿病急性心肌梗死(MI)患者血浆蛋白和血红蛋白的非酶糖基化增加。
J Clin Diagn Res. 2013 Dec;7(12):2692-3. doi: 10.7860/JCDR/2013/7331.3884. Epub 2013 Nov 11.
7
Influence ofL-arginine on glucose mediated collagen cross link precursors in patients with diabetes mellitus.精氨酸对糖尿病患者糖基化胶原交联前体的影响。
Amino Acids. 1991 Feb;1(1):73-80. doi: 10.1007/BF00808093.
8
Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract.患有白内障的糖尿病和非糖尿病患者体内的晚期糖基化终产物
Age (Dordr). 2011 Sep;33(3):377-84. doi: 10.1007/s11357-010-9177-1. Epub 2010 Sep 15.
9
Electron impact mass spectroscopic studies on mouse retinal fatty acids: effect of diabetes.小鼠视网膜脂肪酸的电子轰击质谱研究:糖尿病的影响。
Ophthalmic Res. 2009;42(1):9-14. doi: 10.1159/000219679. Epub 2009 May 28.
10
Immunochemical detection of glycated lens crystallins and their circulating autoantibodies in human serum during aging.衰老过程中人体血清中糖化晶状体蛋白及其循环自身抗体的免疫化学检测。
Mol Vis. 2008;14:2056-66. Epub 2008 Nov 17.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Studies on the oxidation of cysteine to cystine in lens proteins during cataract formation.白内障形成过程中晶状体蛋白中半胱氨酸氧化为胱氨酸的研究。
Am J Ophthalmol. 1951 May;34(5 2):104-13. doi: 10.1016/0002-9394(51)90013-x.
3
Color and solubility of the proteins of human cataracts.人类白内障蛋白质的颜色与溶解性。
Invest Ophthalmol. 1968 Dec;7(6):634-50.
4
Disulphide cross-linked protein of high molecular weight in human cataractous lens.人白内障晶状体中的高分子量二硫键交联蛋白。
Exp Eye Res. 1973 Nov 25;17(4):377-83. doi: 10.1016/0014-4835(73)90247-9.
5
On the presence and mechanism of formation of heavy molecular weight aggregates in human normal and cataractous lenses.关于人正常晶状体和白内障晶状体中重分子量聚集体的存在及其形成机制
Exp Eye Res. 1973 Feb;15(2):185-92. doi: 10.1016/0014-4835(73)90118-8.
6
Age-dependent changes in the molecular size of human lens proteins and their relationship to light scatter.人晶状体蛋白分子大小的年龄依赖性变化及其与光散射的关系。
Invest Ophthalmol. 1974 Oct;13(10):795-8.
7
Mechanisms initiating cataract formation. Proctor Lecture.引发白内障形成的机制。普罗克特讲座。
Invest Ophthalmol. 1974 Oct;13(10):713-24.
8
The proportion of protein from the normal and cataractous human lens which exists as high molecular weight aggregates in vitro.正常和白内障人晶状体中以高分子量聚集体形式存在于体外的蛋白质比例。
Exp Eye Res. 1975 Jan;20(1):73-8. doi: 10.1016/0014-4835(75)90109-8.
9
The concentration and localization of heavy molecular weight aggregates in aging normal and cataractous human lenses.老化的正常和白内障人晶状体中重分子量聚集体的浓度和定位。
Exp Eye Res. 1975 Apr;20(4):367-9. doi: 10.1016/0014-4835(75)90118-9.
10
The state of sulphydryl groups in normal and cataractous human lenses.正常及白内障人晶状体中巯基的状态
Exp Eye Res. 1977 Aug;25(2):139-48. doi: 10.1016/0014-4835(77)90126-9.